Shilpa Biologicals Private Limited, a active private limited company, was established on 09 January 2020 in Dharwad, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230KA2020PTC131456. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹56.28 Cr.
Employing 240 professional, Its leadership includes Ramakant Innani (Managing Director), Madhav Vishnukant Bhutada (Director), Vishnukanth Chaturbhuj Bhutada (Nominee Director). Past directors included Ramakant Innani, Madhav Vishnukant Bhutada, Krishnappayya Desai. It holds ₹2.16 Cr open charges and ₹800.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 532-A, Belur Industrial Area, Dharwad, Dharwad, Karnataka, 580011.
U24230KA2020PTC131456
131456
09 January 2020
₹60.00 Cr
₹56.28 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Shilpa Biologicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakant Innani | Managing Director | 09 Jan 2020 | Current |
| Madhav Vishnukant Bhutada | Director | 10 Aug 2022 | Current |
| Vishnukanth Chaturbhuj Bhutada | Nominee Director | 09 Jan 2020 | Current |
| Anita Bandyopadhyay | Additional Director | 12 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Managing Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shilpa Biologicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.63% increase. The company also saw a substantial fall in profitability, with a 165.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 242.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shilpa Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,618,000.00
₹8,000,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2021 | Others | ₹2.16 Cr | Open |
| 04 Aug 2023 | Others | ₹450.00 Cr | Satisfied |
| 10 Feb 2022 | Hdfc Bank Limited | ₹100.00 Cr | Satisfied |
| 10 Aug 2020 | Hdfc Bank Limited | ₹250.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Shilpa Biologicals has a workforce of 240 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shilpa Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shilpa Biologicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shilpa Biologicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Anita Bandyopadhyay was appointed as a Additional Director was appointed as a Additional Director on 12 Aug 2025 & has been associated with this company since 5 months 4 days . was documented.
Shilpa Biologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Progress on A charge registered on 04 Aug 2023 via Charge ID 100828845 with Others was fully satisfied on 20 Jan 2025. was documented.
Progress on Sridevi Khambhampaty was appointed as a Ceo was appointed as a Ceo on 24 Oct 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Anushiya Bhandari was appointed as a Company Secretary was appointed as a Company Secretary on 09 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.
"The inspection concluded with two observations. There were no repeat observations or Data Integrity (DI) related observations," the company added. .
"We have received Form 483 with five observations, with no repeat observations and any data integrity observations. The observations are mostly procedural in nature," the Shilpa Medicare... .
Shilpa Medicare gets USFDA approval for Irinotecan injection to treat cancer. Yay! It's used for colon or rectum cancer and the US market is worth $18 million. #winning #cancerfighter.
The CIN of Shilpa Biologicals Private Limited is U24230KA2020PTC131456.
Shilpa Biologicals Private Limited is headquartered at Plot No 532-A, Belur Industrial Area, Dharwad, Dharwad, Karnataka, 580011.
Shilpa Biologicals Private Limited was incorporated on 09 January 2020.
The current directors of Shilpa Biologicals Private Limited are
The primary industry of Shilpa Biologicals Private Limited is Manufacturing.
Shilpa Biologicals Private Limited is unlisted.
The authorized capital of Shilpa Biologicals Private Limited is ₹60.00 Cr, and the paid-up capital is ₹56.28 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX